Kleveland P M, Waldum H L
Scand J Gastroenterol. 1987 May;22(4):390-6. doi: 10.3109/00365528708991480.
Monoiodinated gastrin was produced by a gentle Iodo-gen method, followed by gel and ion-exchange chromatography. During storage this tracer has previously been found to retain its immunological activity, whereas its specific binding to rat gastric fundic plasma membranes decreased rapidly. To examine whether the loss of specific binding could be reflected in loss of biological activity, we examined the tracer at regular intervals for immunoreactivity by binding to an antibody directed against the C-terminal bioactive site of the gastrin molecule; for biological activity in the totally isolated, vascularly perfused rat stomach concomitantly stimulated with a phosphodiesterase inhibitor; for specific binding ('receptor binding') to a rat gastric fundic plasma membrane fraction; and for fragmentation and intramolecular changes by fast protein liquid chromatography (FPLC). Biological activity and 'specific' binding showed a parallel decrease to zero during 4 weeks of storage, whereas the immunoreactivity was retained much longer. There was no apparent fragmentation of the gastrin molecule during the 1st month after preparation as evaluated by FPLC. This study accordingly shows that both biological activity and specific binding to a gastric fundic plasma membrane fraction of 125I-gastrin are lost before detectable loss in immunoreactivity and before FPLC-detectable fragmentation of the molecule. Thus, during the early storage period subtle changes in the 125I-gastrin molecule must take place. Since the specific binding is so closely correlated to biological activity, it suggests that the binding actually represents true receptor binding.
单碘化胃泌素采用温和的碘酰法制备,随后进行凝胶和离子交换色谱分离。在储存过程中,此前发现这种示踪剂能保持其免疫活性,而其与大鼠胃底质膜的特异性结合则迅速下降。为了研究特异性结合的丧失是否会反映在生物活性的丧失上,我们定期通过与针对胃泌素分子C端生物活性位点的抗体结合来检测示踪剂的免疫反应性;在同时用磷酸二酯酶抑制剂刺激的完全分离、血管灌注的大鼠胃中检测其生物活性;检测其与大鼠胃底质膜部分的特异性结合(“受体结合”);并用快速蛋白质液相色谱(FPLC)检测其片段化和分子内变化。在储存4周期间,生物活性和“特异性”结合平行下降至零,而免疫反应性保留的时间长得多。制备后第1个月内,通过FPLC评估,胃泌素分子没有明显的片段化。因此,这项研究表明,125I-胃泌素的生物活性和与胃底质膜部分的特异性结合在免疫反应性可检测到丧失之前以及分子FPLC可检测到片段化之前就已经丧失。因此,在储存早期,125I-胃泌素分子必定发生了细微变化。由于特异性结合与生物活性密切相关,这表明这种结合实际上代表真正的受体结合。